ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

ANIX Anixa Biosciences Inc

2.94
-0.03 (-1.01%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Anixa Biosciences Inc ANIX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.03 -1.01% 2.94 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.01 2.85 3.06 2.94 2.97
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202406:45PRNUSAnixa Biosciences to Participate in the Sidoti Micro-Cap..
18/4/202407:20PRNUSAnixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay..
14/3/202407:45PRNUSAnixa Biosciences 2024 Annual Meeting of Stockholders to..
11/3/202407:00PRNUSAnixa Biosciences Announces Presentation at 24th Annual..
12/2/202406:30PRNUSAnixa Biosciences Initiates Dosing in Second Cohort of..
08/2/202415:15EDGAR2Form DEF 14A - Other definitive proxy statements
29/1/202407:50PRNUSAnixa Biosciences Announces Participation in 2024..
23/1/202406:55PRNUSAnixa Biosciences Announces Japanese Patent on Ovarian..
16/1/202418:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202418:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202418:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202418:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202418:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202416:29EDGAR2Form SC 13D/A - General statement of acquisition of..
16/1/202415:43EDGAR2Form S-8 - Securities to be offered to employees in employee..
16/1/202415:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
10/1/202408:00PRNUSAnixa Biosciences to Present at Sidoti Micro-Cap Virtual..
14/12/202306:15PRNUSAnixa Biosciences to Present at Biotech Showcase 2024
07/12/202305:01EDGAR2Form 8-K - Current report
06/12/202317:00PRNUSAnixa Biosciences and Cleveland Clinic Present Positive New..
06/12/202315:05PRNUSAnixa Biosciences to Host Conference Call This Evening to..
27/11/202307:30PRNUSAnixa Biosciences Announces European Patent on Ovarian..
02/11/202309:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202307:30PRNUSAnixa Biosciences to Present at the Ovarian Cancer Research..
23/10/202307:30PRNUSAnixa Biosciences Appoints Accomplished Medical Oncologist..
13/10/202307:30PRNUSAnixa Biosciences Completes Treatment of First Patient..
11/10/202309:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202307:30PRNUSAnixa Biosciences Announces Issuance of Additional U.S...
19/9/202307:30PRNUSAnixa Biosciences Establishes Cancer Business Advisory Board
06/9/202315:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/8/202307:30PRNUSAnixa Biosciences to Participate in September Investor..
28/8/202307:30PRNUSAnixa Biosciences Announces Treatment of Third Patient in..
14/8/202307:30PRNUSAnixa Biosciences Announces Invited Presentation on Ovarian..
07/8/202307:30PRNUSAnixa Biosciences Announces Opening of Enrollment for..
31/7/202317:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202317:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/7/202307:30PRNUSAnixa Biosciences Announces Notice of Allowance of..
21/7/202309:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/7/202307:30PRNUSAnixa Biosciences Announces Issuance of Canadian Patent for..
22/5/202307:30PRNUSAnixa Biosciences Announces Treatment of Second Patient in..

Su Consulta Reciente

Delayed Upgrade Clock